Ascorbic acid enhances 17 β-estradiol-mediated inhibition of oxidized low density lipoprotein formation

Atherosclerosis

Volumn 150, Issue 2, 2000, Pages 275-284

  Hwang, Juliana ^a   Peterson, Hazel ^a   Hodis, Howard N ^a   Choi, Bune ^a   Sevanian, Alex ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

17 estradiol; Ascorbic acid; Coronary heart disease; Estrogen; Low density lipoprotein; Male aortic endothelial cells

Indexed keywords

ASCORBIC ACID; ESTRADIOL; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; AORTA; ARTICLE; ATHEROGENESIS; CELL PROTECTION; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTHELIUM CELL; ESTROGEN METABOLISM; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIOXIDANTS; AORTA; ASCORBIC ACID; BIOLOGICAL MARKERS; CELLS, CULTURED; CORONARY ARTERIOSCLEROSIS; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; ESTRADIOL; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; PROGESTERONE; RABBITS; VITAMIN E;

EID: 0034117556     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00376-7     Document Type: Article

References (51)

1. Godsland I.F., Wynn V., Crook D., Miller N.E. Sex plasma lipoproteins and atherosclerosis: prevailing assumptions and outstanding question. Am. Heart J. 114:1987;1467-1503.
2. McManus J., Mc Eneny J., Thompson W., Young I.S. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. Atherosclerosis. 135:1997;73-81.
3. Manson J.E. Postmenopausal hormone therapy and atherosclerotic disease. Am. Heart J. 128:1994;1337-1343.
4. Gruchow H.W., Anderson A.J., Barboriak J.J., Sobocisnki K.A. Postmenopausal use estrogen and occlusion of coronary arteries. Am. Heart J. 115:1988;954-963.
5. Clarkson T.B., Anthony M.S., Klein K.P. Effects of estrogen on arterial wall structure and function. Drugs. 47:1994;42-51.
6. Mendelsohn M.E., Faras R.H. Estrogen and the blood vessel wall. Curr. Opin. Cardiol. 9:1994;626-691.
7. Behl C., Skutella T., Lezoualc'h F. et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
8. Akishita M., Ouchi Y., Miyoshi H. et al. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis. 125:1996;27-38.
9. Wells K.E., Miguel R., Alexander J.J. Sex hormones affect the calcium signaling response of human adterial cells to LDL. J. Surg. Res. 63:1996;64-72.
10. Cicinelli E., Ignarro L.J., Lograno M., Matteo G., Falco N., Schonauer L.M. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil. Steril. 67:1997;63-66.
11. Shwaery G.T., Vita J.A., Keaney J.F. Antioxidant protection of LDL by physiological concentrations of 17 β-estradiol requirement for estradiol modification. Circulation. 95:1997;1378-1385.
12. Wilcox J.G., Hwang J., Hodis H.N., Sevanian A., Stanczky F.Z., Lobo R.A. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. Fertil. Steril. 67:1997;57-62.
13. Myers S.I., Turnage R.H., Bartula L., Kalley B., Meng Y. Estrogen increases male rat aortic endothelial cell (RAEC) PGI2 release. Prostaglandins Leukot. Essent. Fatty Acids. 54:1996;403-409.
14. Mikkola T., Ranta V., Orpana A., Viinikka L., Ylikorkala O. Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells. Fertil. Steril. 66:1996;389-393.
15. Sulistiyani A.S.J., St. Clair R.W. Effect of 17 β-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture. Arterioscler. Thromb. Vasc. Biol. 17:1997;1691-1700.
16. Spyridopoulos, I, Sullivan AB, Kearney BA, Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial apoptosis estradiol as a survival factor. Circulation 1997;95:1505-14.
17. Deshpande R., Khalili H., Pergolizzi R.G., Michael S.D., Chang M.Y. Estradiol down regulated LPS-induced cytokine production and NFκB activation in murine macrophages. Am. J. Reprod. Immunol. 38:1997;46-54.
18. Steinberg D. A critical look at the evidence for the oxidation of LDL in atherogenesis. Atherosclerosis. 131:1997;S5-S7.
19. Berliner J.A., Heineicke J.W. The role of oxidized lipoproteins in atherogenesis. Free. Rad. Biol. Med. 20:1996;707-727.
20. -). J. Lipid Res. 35:1994;669-677.
21. Keaney J.F., Shwaery G.T., Xu A., Nicolosi R.J., Loscalzo J., Foxall T.L., Vita J.A. 17(-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259.
22. Samsioe G. Cardioprotection by estrogens: mechanisms of action- the lipids. Int. J. Fertil. 39:1994;43-49.
23. Rifici V.A., Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism. 41:1992;1110-1114.
24. Neugarten J., Ghossein C., Silbiger S. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein. J. Lab. Clin. Med. 126:1995;385-391.
25. Sevanian A., Hwang J., Hodis H.N., Cazzolato G., Avogaro P., Bittolo-Bon G. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulation. Arterioscler. Thromb. Vasc. Biol. 16:1996;784-793.
26. Tribble D.L., Holl L.G., wood P.D., Krauss R.M. Variations in oxidative susceptibility among six low-density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 93:1992;189-199.
27. Wakatsuki A., Nobuo I., Sagara Y. Effects of estrogen on susceptibility to oxidation of low-density and high density lipoprotein in postmenopausal women. Maturitas. 28:1998;229-234.
28. Sack M.N., Rafer D.J., Cannon I.I.I. R.O. Oestrogen and inhibition of oxidation of low-density lipoprotein in postmenopausal women. Lancet. 343:1994;269-270.
29. Brussaard H.E., Leuven J.A.G., Kluft C., Krans M.J., van Duyvenvoorde W., Buytenhek R., van der Laarse A., Princen H.M.G. Effect of 17 β-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 17:1997;324-330.
30. Rose R.C., Bode A.M. Biology of free radical scavengers: an evaluation of ascorbate. Faseb. J. 7:1993;1135-1142.
31. Burr M.T., Sweetman P.T., Hurley R.J., Powell G.H. Effects of age and intake on plasma ascorbic acid levels. Lancet. 1:1974;163-164.
32. Morgan A.F., Fillum H.L., Williams R.I. Nutritional status of aging. III Serum ascorbic acid intake. J. Nutr. 55:1955;431-448.
33. Itoh R., Yamada K., Oka J., Echizen H., Murakami K. Sex as a factor in levels of serum ascorbic acid in healthy elderly population. Int. J. Vitamin Nutr. Res. 59:1989;365-572.
34. Barja G. Ascorbic acid and aging. Harris J.R. Subcellular Biochemistry 25. 1996;157-187 Plenum, New York.
35. Martin A., Frei B. Both intracellular and extracellular vitamin C inhibit atherogenesic modification of LDL by human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;1583-1590.
36. Bui M.H. Simple determination of retinol, α-tocopherol and carotenoids (lutein, all trans-lycopene, α and β carotenes) in human plasma by isocratic liquid chromatography. J. Chromatogr. B: Biomed. Appl. 654:1994;129-133.
37. Day B.R., Williams D.R., Marsh C.A. A rapid manual method for routine assay of ascorbic acid in serum and plasma. Clin. Biochem. 12:1979;22-26.
38. 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture. Am. J. Pathol. 121:1985;200-211.
39. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am. J. Clin. Nutr. 54:1991;1119S-1124S.
40. Frei B. Ascorbic acid protects lipids in humnan plasma low densisty lipoprotein against oxidative damage. Am. J. Clin. Nutr. 54:1991;1113S-1118S.
41. Retsky K.L., Chen K., Zeind J., Frei B. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation. Free. Rad. Biol. Med. 26:1999;90-98.
42. Ingold K.U., Bowry V.W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids:unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:1993;45-49.
43. Niki, E, Nakano M. Oxygen radicals in biological systems. Estrogens as antioxidants. In: Lester, P., Glazer, A.N., editors. Methods Enzymol 1990;186:330-333.
44. Maiorino M., Zamburlini A., Roveri A., Ursini F. Prooxidant role of vitamin E in copper induced lipid peroxidation. FEBS. 330:1993;1174-1176.
45. Neuzil J., Thomas S.R., Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free. Rad. Biol. Med. 22:1997;57-71.
46. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.G., Witzum J.L. Beyond cholesterol: modifications of low density lipoprotoein that increase its atherogenicity. N. Engl. J. Med. 32:1989;915-924.
47. Watson A.D., Navab M., Hama S.Y. et al. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95:1995;774-782.
48. Huber L.A., Scheffler E., Poll T., Ziegler R., Dresel H.A. 17 beta-estradiol inhibits LDL oxidation and cholesterol ester formation in cultured macrophages. Free. Radic. Res. Commun. 8:1990;167-173.
49. Negre-Salvayre A., Pieraggi M.T., Mabile L., Salvayre R. Protective effect of 17 β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 99:1993;207-217.
50. Maziere C., Auclair M., Ronveaux M.F., Salmon S., Santus R., Maziere J.C. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis. 89:1991;175-182.
51. Tang M., Abplanalp W., Ayres S., Subbiah R. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism. 45:1996;411-414.